ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,523, issued on May 20, was assigned to DALE BIOTECH LLC (Oakland, Calif.).
"Method for treating dupuytren's disease" was invented by Anton Leighton (Oakland, Calif.) and Ralph T. Salvagno (Hancock, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to methods for treating Dupuytren's disease, osteoarthritis, and adhesive capsulitis. The method comprises the steps of identifying a subject in need thereof, and administering to the subject an effective amount of one or more rhamnolipids, optionally in combination with niclosamide. A pharmaceutical composition comprising rhamnolipids, optionally in combination with nicl...